Market capitalization is the total value the stock market puts on a company: its share price multiplied by the number of shares outstanding. Each point here is the share count reported in a filing multiplied by the closing price on that filing date, adjusted for later stock splits, so the history moves when a new filing arrives rather than with each day's trading. A larger market cap means investors collectively value the company more highly; by itself it says nothing about profit or debt. Annual points keep the latest observation in each calendar year.
Design Therapeutics, Inc. market cap for the quarter ending 2026-07-29 was $750.98M, a 245.21% increase year-over-year.
Design Therapeutics, Inc. market cap for the quarter ending 2026-06-30 was $904.91M, a 371.51% increase year-over-year.
Design Therapeutics, Inc. market cap for the quarter ending 2026-04-23 was $798.82M, a 202.61% increase year-over-year.
Design Therapeutics, Inc. market cap for the quarter ending 2026-03-31 was $664.38M, a 203.19% increase year-over-year.
Design Therapeutics, Inc. market cap for fiscal 2026 was $750.98M.
Design Therapeutics, Inc. market cap for fiscal 2025 was $566.53M, a 61.79% increase from fiscal 2024.
Design Therapeutics, Inc. market cap for fiscal 2024 was $350.17M, a 133.99% increase from fiscal 2023.
Design Therapeutics, Inc. market cap for fiscal 2023 was $149.66M, a 73.90% decline from fiscal 2022.